Rho GTPases: potential candidates for anticancer therapy

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Rho GTPases are key regulators of cellular processes including proliferation, migration, and apoptosis.
• Overexpression of Rho GTPases is frequently observed in human tumors, implicating them in carcinogenesis.
• Understanding Rho GTPase signaling pathways is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To review the biological functions of Rho GTPases in tumor biology.
• To summarize recent advancements in understanding Rho GTPase downstream effectors and transcription factors in tumorigenesis.
• To describe novel drugs targeting Rho signaling with antineoplastic and antimetastatic potential.

Main Methods:

• Literature review of Rho GTPase functions in cancer.
• Analysis of downstream effectors and transcription factors involved in Rho-mediated tumorigenesis.
• Compilation of data on targeted therapeutic agents affecting Rho signaling.

Main Results:

• Rho GTPases control fundamental cellular processes critical for tumor cell proliferation and motility.
• Aberrant Rho signaling contributes significantly to tumor development and metastasis.
• Specific drugs targeting Rho signaling pathways have demonstrated antineoplastic and antimetastatic efficacy.

Conclusions:

• Rho GTPases are pivotal in cancer progression, making them attractive therapeutic targets.
• Targeted interventions in Rho signaling pathways hold promise for effective cancer treatment.
• Further research into Rho GTPase biology and targeted therapies can lead to improved patient outcomes.